Lanio N, Sarmiento E, Gallego A, Carbone J
Immunology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Allergol Immunopathol (Madr). 2009 Jan-Feb;37(1):14-20. doi: 10.1016/s0301-0546(09)70246-0.
A system based on the B-cell phenotype has recently been proposed to classify patients suffering from common variable immunodeficiency (CVID). Immunophenotypic T-cell abnormalities have also been correlated with clinical findings, although they have never been used in classification strategies.
To simultaneously assess T and B-cell subset abnormalities in CVID patients and their relationship with clinical findings. To identify potential immunophenotypic T-cell abnormalities that could be further evaluated in multicenter studies.
Peripheral blood lymphocytes from 21 CVID patients and 21 healthy donors were stained for T and B-cell subsets, analyzed by flow cytometry, and correlated with clinical characteristics.
Patients classified as MB0 (CD19/CD27+ < 11 %) showed higher percentages of CD4/ CD45RA (87 % vs 67 %, p = 0.028) and lower percentages of CD8/CD45RA+CCR7+ (10 % vs 26 %, p = 0.028) and CD4/CD25+ T-cells (36 % vs 62 %, p = 0.034) than MB2 patients. Even though our cohort was small, we observed a higher prevalence of distinct clinical complications of CVID in patients with B and T-cell abnormalities. Nonmalignant lymphoproliferative disorders and IgG hypercatabolism were more frequently observed in MB0 patients. A higher prevalence of splenomegaly was observed among CVID patients with increased levels of CD4/CD45RA, activated CD4/CD38+DR+, CD8/DR+, and CD8/CD38+ T-cells, as well as in those with lower percentages of CD4/CD45RA+CCR7+ and CD4/CD25+ T-cells. Lymphoproliferative disorders were more prevalent among CVID patients with higher CD4/CD45RA percentages.
The study of T-cell subsets warrants further evaluation as a potential tool to better identify CVID patients with distinct clinical profiles.
最近有人提出了一种基于B细胞表型的系统,用于对患有常见变异型免疫缺陷(CVID)的患者进行分类。免疫表型T细胞异常也与临床发现相关,尽管它们从未被用于分类策略中。
同时评估CVID患者的T细胞和B细胞亚群异常及其与临床发现的关系。识别可能在多中心研究中进一步评估的潜在免疫表型T细胞异常。
对21例CVID患者和21名健康供体的外周血淋巴细胞进行T细胞和B细胞亚群染色,通过流式细胞术进行分析,并与临床特征相关联。
分类为MB0(CD19/CD27+ < 11%)的患者,其CD4/CD45RA百分比更高(87%对67%,p = 0.028),CD8/CD45RA+CCR7+(10%对26%,p = 0.028)和CD4/CD25+ T细胞百分比更低(36%对62%,p = 0.034),与MB2患者相比。尽管我们的队列规模较小,但我们观察到B细胞和T细胞异常的CVID患者出现不同临床并发症的患病率更高。非恶性淋巴增殖性疾病和IgG高分解代谢在MB0患者中更常见。在CD4/CD45RA、活化的CD4/CD38+DR+、CD8/DR+和CD8/CD38+ T细胞水平升高的CVID患者中,以及在CD4/CD45RA+CCR7+和CD4/CD25+ T细胞百分比更低的患者中,脾肿大的患病率更高。淋巴增殖性疾病在CD4/CD45RA百分比更高的CVID患者中更普遍。
T细胞亚群的研究作为一种潜在工具,用于更好地识别具有不同临床特征的CVID患者,值得进一步评估。